SterRx Sodium Bicarbonate Injection Recalled for Non-Sterility
SterRx is recalling Sodium Bicarbonate in 5% Dextrose Injection due to microbial contamination confirmed by third-party laboratory testing. The affected product is a prescription intravenous injection distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall of a sterile injectable drug with confirmed microbial contamination. Non-sterile intravenous products pose direct risk of serious infection, sepsis, or other life-threatening complications in patients, even without reported illnesses stated in the source text.
Plain-English summary
SterRx, LLC is recalling Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), in 1,000 mL bags (NDC 70324-326-01). The recall was initiated because a third-party laboratory confirmed microbial contamination in the product, meaning the solution is not sterile as required for intravenous injection.
Lot Number BUP with expiration date 03/23/22 is affected. Approximately 1,098 bags were distributed nationwide in the United States as a prescription-only medication.
Patients and healthcare providers who have received or are using this product should stop use immediately and consult with a healthcare professional about potential exposure. Healthcare facilities should quarantine and return remaining inventory of the affected lot to the manufacturer.
The recalled product
- Product
- Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL bags, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903 NDC 70324-326-01
- Manufacturer
- SterRx, LLC
- Category
- Drug — Intravenous Injection
- Affected units
- 1,098
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot Number: BUP
- exp. date 03/23/22
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by SterRx, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · SterRx, LLC
See all →- HighNorepinephrine injectable recalled due to sterility assurance concerns
FDA (Drugs) · 2023-07-26
- HighNorepinephrine injectable recalled due to lack of sterility assurance
FDA (Drugs) · 2023-07-26
- HighNorepinephrine injectable medication recalled nationwide for sterility assurance
FDA (Drugs) · 2023-07-26
- HighNorepinephrine Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-07-26
- HighSodium Bicarbonate Injectable Solution Recalled for Sterility Assurance Issues
FDA (Drugs) · 2023-07-26
Same hazard · non sterility
See all →- SevereChloraPrep One-Step Topical Antiseptic Recalled for Non-Sterility
FDA (Drugs) · 2026-07-01
- SevereChloraPrep One-Step Antiseptic Solution Recall Due to Sterility Concerns
FDA (Drugs) · 2026-07-01
- HighLSL Healthcare Central Line Dressing Change Kit Recalled for Non-Sterility
FDA (Devices) · 2026-04-29
- HighCentral Line Dressing Kit containing non-sterile alcohol prep pads recalled
FDA (Devices) · 2026-04-29
- SevereIV Start Kit with Non-Sterile Alcohol Prep Pads Recalled
FDA (Devices) · 2026-04-29